CMS Sets The Stage For New Medicare "Coverage With Evidence Development" Guidance

A rarely-used tool for gathering data on medical technologies will get a fresh look as the agency solicits public comment on how to make CED a more meaningful and effective part of its coverage decision-making process.

CMS is seeking public input on its policy of “coverage with evidence development” as it considers how to more effectively use this tool when making coverage decisions, particularly with new technologies that may not have sufficient data on effectiveness at time coverage begins.

In a Nov. 7 comment solicitation on the agency’s website, CMS noted that it is seeking feedback with the intention...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers